Abstract:Abstract The specificity of antibodies, CAR-T cells and other biologic therapeutics to their binding targets is important to evaluate drug quality. The non-specific binding may lead serious toxic side effects. Therefore, specificity detection is an important step in the evaluation process of drug development. At present, the non-specific binding of antibody drugs is often verified only after serious adverse reactions founding in clinical trials, which may result in drug safety accidents and the abandonment of previous studies. To address the need for antibody target deconvolution and receptor identification, we developed a novel approach “AB5000”. AB5000 is an excellent solution for antibody specificity screening which enable early off-target screening and can de-risk the antibody drug development program. The AB5000 makes use of the full coverage membrane protein, representing over 5465 unique human membrane proteins including receptors, transporters, enzymes, miscellaneous and other membrane protein. Gene vector was transfected into target cells. Each membrane protein introduces a C-terminal epitope tag, allowing confirmation of protein expression and cellular location. To provide the highest level of sensitivity, we use luciferase reporter cell line system which is more rapid, simple and highly sensitive than flow cytometry or other binding assays. The AB5000 has widely application in testing the specificity of antibodies, deconvolution of orphan antibodies and ligands, detection of CAR-T proteins. The AB5000 represents a rapid, comprehensive, and highly sensitive platform for identifying the membrane protein targets of a wide variety of antibodies, protein ligands, and functional interactions. It is a promising powerful tool for biotherapeutic modalities development. Citation Format: dan Li, Junyi Xiong, Jinying Ning, Feng Hao. A high-throughput platform for targets screening by membrane protein library [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2645.

Deciphering Membrane‐Protein Interactions and High‐Throughput Antigen Identification with Cell Doublets

Deciphering Membrane‐Protein Interactions and High‐Throughput Antigen Identification with Cell Doublets (Adv. Sci. 13/2024)

Identification of Human T Cell Receptor Γδ-Recognized Epitopes/Proteins Via CDR3δ Peptide-based Immunobiochemical Strategy

High-throughput Determination of the Antigen Specificities of T Cell Receptors in Single Cells

Multiplex in Situ Tagging Technology for Highly Multiplexed Single-Cell Analysis

Identification of tumor-specific MHC ligands through improved biochemical isolation and incorporation of machine learning

Highly Paralleled Emulsion Droplets for Efficient Isolation, Amplification, and Screening of Cancer Biomarker Binding Phages.

High-throughput and multimodal profiling of antigen-specific T cells with a droplet-based cell-cell interaction screening platform

A general platform for targeting MHC-II antigens via a single loop

Development of an Antigen-Antibody Co-Display System for Detecting Interaction of G-Protein-Coupled Receptors and Single-Chain Variable Fragments

T-FINDER: A highly sensitive, pan-HLA platform for functional T cell receptor and ligand discovery

pan-MHC and cross-Species Prediction of T Cell Receptor-Antigen Binding

High-throughput screening of functional neo-antigens and their specific TCRs via the Jurkat reporter system combined with droplet microfluidics

Deciphering Cell–Cell Interactions with Integrative Single‐Cell Secretion Profiling

Discovery of antibodies targeting multipass transmembrane proteins using a suspension cell-based evolutionary approach

Deciphering CD4+ T cell specificity using novel MHC–TCR chimeric receptors

A Microfluidic Chip For Screening And Sequencing Of Monoclonal Antibody At A Single-Cell Level

Preparation empty peptide-receptive MHC class I complex for large-scale detection through photolabile peptide ligands

A general system for targeting MHC class II–antigen complex via a single adaptable loop

Rapid screening of TCR-pMHC interactions by the YAMTAD system

Abstract 2645: A high-throughput platform for targets screening by membrane protein library